undamentalytics Newsletter
Sign in

ASP Isotopes Inc. key statistics and ratios

In fiscal 2025, ASP Isotopes Inc. had return on equity of -126.8% and a net margin of -670.2%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Net margin—<−999%−782.4%−670.2%−380.3%
Return on equity−50.4%−124.8%−101.0%−126.8%−50.1%
Return on assets−39.6%−81.4%−53.2%−54.0%−21.9%
R&D as % of revenue—176.6%75.7%51.8%71.4%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

4 of 6 checks passed · June 30, 2026
What it owns · $572m
Short-term assets $272mLonger-term assets $300m
What it owes, and who funded it · $562m
Short-term liabilities $70mLonger-term liabilities $227mShareholders' equity $265m
  • Short-term assets cover short-term liabilities $272m of assets due within a year against $70m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $272m short-term assets against $227m of longer-dated liabilities.
  • More cash than debt $220m of cash against $60m of debt.
  • Debt below 40% of shareholders' equity Debt is 23% of equity.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt −$68m of operating cash flow against $60m of debt.
  • Operating profit covers interest at least five times over Operating income of −$99m against $4m of interest.

From ASP Isotopes Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: ASPI vs CNEYASPI vs TANHASPI vs BONASPI vs PMA

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from ASP Isotopes Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to ASP Isotopes Inc.